683
Views
32
CrossRef citations to date
0
Altmetric
Review

Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer’s Disease

, , , , , & show all
Pages 195-205 | Published online: 13 Feb 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Wei Wei, Yongli Pan, Xinyu Yang, Zhonglun Chen, Yue Heng, Bufan Yang, Mingjun Pu, Jiacai Zuo, Zhuhong Lai, Yufeng Tang & Wenqiang Xin. (2022) The Emerging Role of the Interaction of Extracellular Vesicle and Autophagy—Novel Insights into Neurological Disorders. Journal of Inflammation Research 15, pages 3395-3407.
Read now
Qin Ouyang, Yingcai Meng, Wenhu Zhou, Jianbin Tong, Zeneng Cheng & Qubo Zhu. (2022) New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease. Journal of Drug Targeting 30:1, pages 61-81.
Read now

Articles from other publishers (30)

Simran Chauhan, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Sumeet Gupta, Mohammed Albratty, Asim Najmi, Abdulkarim M. Meraya & Hassan A. Alhazmi. (2022) Understanding the Intricate Role of Exosomes in Pathogenesis of Alzheimer’s Disease. Neurotoxicity Research 40:6, pages 1758-1773.
Crossref
Qiao-mei Huang, Ying-ying Zhou, He-fan He, Shu Lin & Xiang-rong Chen. (2022) Research Progress on Exosomes and MicroRNAs in the Microenvironment of Postoperative Neurocognitive Disorders. Neurochemical Research 47:12, pages 3583-3597.
Crossref
Alok Raghav, Manish Singh, Goo-Bo Jeong, Richa Giri, Saurabh Agarwal, Sanjay Kala & Kirti Amresh Gautam. (2022) Extracellular vesicles in neurodegenerative diseases: A systematic review. Frontiers in Molecular Neuroscience 15.
Crossref
Xun Gong, Hantao Zhang, Xiaoyan Liu, Yi Liu, Junlin Liu, Funmilayo O. Fapohunda, Peng Lü, Kun Wang & Min Tang. (2022) Is liquid biopsy mature enough for the diagnosis of Alzheimer’s disease?. Frontiers in Aging Neuroscience 14.
Crossref
Shiting Weng, Qi-Lun Lai, Junjun Wang, Liying Zhuang, Lin Cheng, Yejia Mo, Lu Liu, Zexian Zhao, Ying Zhang & Song Qiao. (2022) The Role of Exosomes as Mediators of Neuroinflammation in the Pathogenesis and Treatment of Alzheimer’s Disease. Frontiers in Aging Neuroscience 14.
Crossref
Yun Shi, Qianqian Bao, Weidong Chen, Lei Wang, Daiyin Peng, Jie Liu, Qing Liu, Yanchun Zhang, Zhaojie Ji & Aizong Shen. (2022) Potential Roles of Extracellular Vesicles as Diagnosis Biomarkers and Therapeutic Approaches for Cognitive Impairment in Alzheimer’s Disease. Journal of Alzheimer's Disease 87:1, pages 1-15.
Crossref
Suren A. Tatulian. (2022) Challenges and hopes for Alzheimer’s disease. Drug Discovery Today 27:4, pages 1027-1043.
Crossref
Ali Mahmoudi, Alexandra E. Butler, Tannaz Jamialahmadi & Amirhossein Sahebkar. (2022) The role of exosomal miRNA in nonalcoholic fatty liver disease. Journal of Cellular Physiology 237:4, pages 2078-2094.
Crossref
Sojin Song, Jong Uk Lee, Myeong Jin Jeon, Soohyun Kim & Sang Jun Sim. (2022) Detection of multiplex exosomal miRNAs for clinically accurate diagnosis of Alzheimer’s disease using label-free plasmonic biosensor based on DNA-Assembled advanced plasmonic architecture. Biosensors and Bioelectronics 199, pages 113864.
Crossref
Jacopo Meldolesi. (2022) News about Therapies of Alzheimer’s Disease: Extracellular Vesicles from Stem Cells Exhibit Advantages Compared to Other Treatments. Biomedicines 10:1, pages 105.
Crossref
Carl Randall Harrell, Ana Volarevic & Vladislav Volarevic. 2022. Handbook of Stem Cell Therapy. Handbook of Stem Cell Therapy 413 436 .
Carl Randall Harrell, Ana Volarevic & Vladislav Volarevic. 2022. Handbook of Stem Cell Therapy. Handbook of Stem Cell Therapy 1 24 .
HyeJu Jeong, Ok Joon Kim, Seung-Hun Oh, Sanghoon Lee, Han A. Reum Lee, Kee Ook Lee, Boo-Yong Lee & Nam Keun Kim. (2021) Extracellular Vesicles Released from Neprilysin Gene-Modified Human Umbilical Cord-Derived Mesenchymal Stem Cell Enhance Therapeutic Effects in an Alzheimer’s Disease Animal Model. Stem Cells International 2021, pages 1-20.
Crossref
Jacopo Meldolesi. (2021) Extracellular vesicles (exosomes and ectosomes) play key roles in the pathology of brain diseases. Molecular Biomedicine 2:1.
Crossref
Yinyin Tan, Yanqun Zheng, Daiwen Xu, Zhanfang Sun, Huan Yang & Qingqing Yin. (2021) Galectin-3: a key player in microglia-mediated neuroinflammation and Alzheimer's disease. Cell & Bioscience 11:1.
Crossref
Jared Mattingly, Yuchen Li, Ji C. Bihl & Jinju Wang. (2021) The promise of exosome applications in treating central nervous system diseases. CNS Neuroscience & Therapeutics 27:12, pages 1437-1445.
Crossref
Sharanjot Kaur, Harkomal Verma, Monisha Dhiman, Gianluca Tell, Gian Luigi Gigli, Francesco Janes & Anil K. Mantha. (2021) Brain Exosomes: Friend or Foe in Alzheimer’s Disease?. Molecular Neurobiology 58:12, pages 6610-6624.
Crossref
Hagar M. Soliman, Ghada A. Ghonaim, Shaza M. Gharib, Hitesh Chopra, Aya K. Farag, Mohamed H. Hassanin, Abdalrazeq Nagah, Mahmoud Emad-Eldin, Nevertary E. Hashem, Galal Yahya, Sherif E. Emam, Abdalla E. A. Hassan & Mohamed S. Attia. (2021) Exosomes in Alzheimer’s Disease: From Being Pathological Players to Potential Diagnostics and Therapeutics. International Journal of Molecular Sciences 22:19, pages 10794.
Crossref
Pragya Prasanna, Shweta Rathee, Vedanabhatla Rahul, Debabrata Mandal, Macherla Sharath Chandra Goud, Pardeep Yadav, Susan Hawthorne, Ankur Sharma, Piyush Kumar Gupta, Shreesh Ojha, Niraj Kumar Jha, Chiara Villa & Saurabh Kumar Jha. (2021) Microfluidic Platforms to Unravel Mysteries of Alzheimer’s Disease: How Far Have We Come?. Life 11:10, pages 1022.
Crossref
Alexandre Androuin, Frederik J. Verweij & Guillaume van Niel. (2021) Zebrafish as a preclinical model for Extracellular Vesicle-based therapeutic development. Advanced Drug Delivery Reviews 176, pages 113815.
Crossref
Luyao Huo, Xinzhe Du, Xinrong Li, Sha Liu & Yong Xu. (2021) The Emerging Role of Neural Cell-Derived Exosomes in Intercellular Communication in Health and Neurodegenerative Diseases. Frontiers in Neuroscience 15.
Crossref
Ka Young Kim, Ki Young Shin & Keun-A Chang. (2021) Brain-Derived Exosomal Proteins as Effective Biomarkers for Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Biomolecules 11:7, pages 980.
Crossref
Tongmei Zhang, Sehui Ma, Junkai Lv, Xinyuan Wang, Henok Kessete Afewerky, Hao Li & Youming Lu. (2021) The emerging role of exosomes in Alzheimer’s disease. Ageing Research Reviews 68, pages 101321.
Crossref
Barbara Miziak, Barbara Błaszczyk & Stanisław J. Czuczwar. (2021) Some Candidate Drugs for Pharmacotherapy of Alzheimer’s Disease. Pharmaceuticals 14:5, pages 458.
Crossref
Gilar Gorji‐bahri, Hamid Reza Moghimi & Atieh Hashemi. (2020) RAB5A is associated with genes involved in exosome secretion: Integration of bioinformatics analysis and experimental validation . Journal of Cellular Biochemistry 122:3-4, pages 425-441.
Crossref
Isha Gaurav, Abhimanyu Thakur, Ashok Iyaswamy, Xuehan Wang, Xiaoyu Chen & Zhijun Yang. (2021) Factors Affecting Extracellular Vesicles Based Drug Delivery Systems. Molecules 26:6, pages 1544.
Crossref
Jacopo Meldolesi. (2021) News about the Role of Fluid and Imaging Biomarkers in Neurodegenerative Diseases. Biomedicines 9:3, pages 252.
Crossref
Pragya Prasanna & Arun Upadhyay. (2021) Flavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go. ACS Pharmacology & Translational Science 4:1, pages 74-95.
Crossref
Ahmed Elsherbini & Erhard Bieberich. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4 203 214 .
Minyeoung Kweon, Jae Yeon Kim, Ji Hye Jun & Gi Jin Kim. (2020) Research Trends in the Efficacy of Stem Cell Therapy for Hepatic Diseases Based on MicroRNA Profiling. International Journal of Molecular Sciences 22:1, pages 239.
Crossref